Merck & Co has joined with the non-profit scientific research organisation, the International AIDS Vaccine Initiative (IAVI), to develop a potential vaccine against the SARS-CoV-2 coronavirus that ...

The US Food and Drug Administration has delayed granting full approval of Novavax’s Covid-19 vaccine despite it being on ...

Merck & Co’s CEO Kenneth Frazier has warned that the drugs and vaccines in the pipeline to combat COVID-19 may not be enough to swiftly end the pandemic. Speaking to CNBC, Frazier said that the ...

“Cleveland Clinic: Millions of COVID-vaxxed will die within ‘5 years,’” the headline said. This Facebook post was flagged as ...

Dr. Peter Marks made clear that a central impetus behind his resignation was Kennedy’s criminal response to the deepening ...

Five years ago, volunteers rolled up their sleeves in the first clinical trial of a vaccine against COVID-19, as the new ...

Novavax started the week hoping the FDA would issue a full approval of its Covid vaccine. But the decision never came.

A number of companies are racing to develop drugs to combat the pandemic beyond vaccines ... risk of severe COVID-19. The news boosted Pfizer’s share price while pummelling Merck’s.

The agency is sitting on a decision to grant full approval for Novavax’s shot, days after top vaccine regulator pushed out.

Shares of Novavax (NVAX) are under pressure on Thursday following Robert F. Kennedy Jr.’s comments on the company’s COVID shot approval delay.

The U.S. Food and Drug Administration has missed its deadline for making a decision on traditional approval for Novavax's ...